http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-940019706-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08 |
| filingDate | 1994-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1994-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-940019706-A |
| titleOfInvention | Di-substituted 2-amino-thiazole derivatives |
| abstract | FIELD OF THE INVENTION The present invention relates to multisubstituted 2-amino-thiazole derivatives, in particular medical products for combating pathologies that require the stimulation of the cholecystoquinin receptor by whole or partial agonist effects upon treatment. Compounds of the following general formula (1) for the preparation of pharmaceutically preferred salts and solvates thereof and their use.n n n n n n n n [Wherein, Y is a 3-quinolyl group or a 2-indolyl group of the following general formula.n n n n n n n n (Wherein -R is hydrogen, an acetyl group or CH 2 COOR 'group, R' is hydrogen or C 1 -C 4 -alkyl; -X is 4-chloro-2,6-dimethoxyphenyl, 2, 6-dimethoxy-4-methylphenyl, 2,3,4, -trimethoxyphenyl, 4-methyl-2,3,6-trimethoxyphenyl, 2,6-dimethoxy-4-ethylphenyl, 2, 4,6-trimethoxy-5-chloro-phenyl, 2,4,6-trimethoxy-3-pyridyl, 2,4-dimethoxy-6-methyl-3-pyridyl, 6-chloro-2 , 4-dimethoxy-5-pyrimidinyl, 2,4,6-trimethoxy-5-pyrimidyl, 5-chloro-2,4-dimethoxyphenyl, 5-chloro-2-methoxy-4- Methylphenyl, 2,5-dimethoxy-4-methylphenyl, 4-trifluoromethyl-2,6-dimethoxyphenyl, 2,4-dimethoxy-5-methylphenyl, 5-ethyl-2,4-dimethoxyphenyl And (hetero) aryl radicals selected from 2,4-dimethoxyphenyl groups, -Z is H, C 1 -C 4 -alkyl or benzyl, provided that Z is a phenyl radical wherein X is substituted at positions 2 and 6 simultaneously 3-pyridyl, wherein X is substituted at positions 2 and 4 simultaneously Radical or can ever X is 5-pyrimidyl radical substituted simultaneously at positions 4 and 6 hydrogen.)]. |
| priorityDate | 1993-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.